Metabolic and morphological alterations induced by proteolysis-inducing factor from Walker tumour-bearing rats in C2C12 myotubes

Claudia L. Yano, Gislaine Ventrucci, William N. Field, Michael J. Tisdale, Maria Cristina C. Gomes-Marcondes

Research output: Contribution to journalArticle

Abstract

BACKGROUND: Patients with advanced cancer suffer from cachexia, which is characterised by a marked weight loss, and is invariably associated with the presence of tumoral and humoral factors which are mainly responsible for the depletion of fat stores and muscular tissue. METHODS: In this work, we used cytotoxicity and enzymatic assays and morphological analysis to examine the effects of a proteolysis-inducing factor (PIF)-like molecule purified from ascitic fluid of Walker tumour-bearing rats (WF), which has been suggested to be responsible for muscle atrophy, on cultured C2C12 muscle cells. RESULTS: WF decreased the viability of C2C12 myotubes, especially at concentrations of 20-25 mug.mL-1. There was an increase in the content of the pro-oxidant malondialdehyde, and a decrease in antioxidant enzyme activity. Myotubes protein synthesis decreased and protein degradation increased together with an enhanced in the chymotrypsin-like enzyme activity, a measure of functional proteasome activity, after treatment with WF. Morphological alterations such as cell retraction and the presence of numerous cells in suspension were observed, particularly at high WF concentrations. CONCLUSION: These results indicate that WF has similar effects to those of proteolysis-inducing factor, but is less potent than the latter. Further studies are required to determine the precise role of WF in this experimental model. © 2008 Yano et al; licensee BioMed Central Ltd.
LanguageEnglish
Pages24-
JournalBMC Cancer
Volume8
Issue number24
DOIs
Publication statusPublished - 28 Jan 2008

Fingerprint

Skeletal Muscle Fibers
Proteolysis
Inbred WF Rats
Neoplasms
Cachexia
Muscular Atrophy
Ascitic Fluid
Enzyme Assays
Proteasome Endopeptidase Complex
Malondialdehyde
Muscle Cells
Weight Loss
Reactive Oxygen Species
Suspensions
Theoretical Models
Antioxidants
Fats
Enzymes
Proteins
Therapeutics

Bibliographical note

© 2008 Yano et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Keywords

  • advanced cancer
  • cachexia
  • weight loss
  • tumoral factors
  • humoral factors
  • fat stores
  • muscular tissue
  • cytotoxicity assays
  • enzymatic assays
  • morphological analysis
  • proteolysis-inducing factor (PIF)-like molecule
  • ascitic fluid of
  • Walker tumour-bearing rats
  • muscle atrophy
  • cultured C2C12 muscle cells
  • C2C12 myotubes
  • pro-oxidant malondialdehyde
  • chymotrypsin-like enzyme activity

Cite this

Yano, Claudia L. ; Ventrucci, Gislaine ; Field, William N. ; Tisdale, Michael J. ; Gomes-Marcondes, Maria Cristina C. / Metabolic and morphological alterations induced by proteolysis-inducing factor from Walker tumour-bearing rats in C2C12 myotubes. In: BMC Cancer. 2008 ; Vol. 8, No. 24. pp. 24-.
@article{429f14a7728444edaea3cf4bb1455ce8,
title = "Metabolic and morphological alterations induced by proteolysis-inducing factor from Walker tumour-bearing rats in C2C12 myotubes",
abstract = "BACKGROUND: Patients with advanced cancer suffer from cachexia, which is characterised by a marked weight loss, and is invariably associated with the presence of tumoral and humoral factors which are mainly responsible for the depletion of fat stores and muscular tissue. METHODS: In this work, we used cytotoxicity and enzymatic assays and morphological analysis to examine the effects of a proteolysis-inducing factor (PIF)-like molecule purified from ascitic fluid of Walker tumour-bearing rats (WF), which has been suggested to be responsible for muscle atrophy, on cultured C2C12 muscle cells. RESULTS: WF decreased the viability of C2C12 myotubes, especially at concentrations of 20-25 mug.mL-1. There was an increase in the content of the pro-oxidant malondialdehyde, and a decrease in antioxidant enzyme activity. Myotubes protein synthesis decreased and protein degradation increased together with an enhanced in the chymotrypsin-like enzyme activity, a measure of functional proteasome activity, after treatment with WF. Morphological alterations such as cell retraction and the presence of numerous cells in suspension were observed, particularly at high WF concentrations. CONCLUSION: These results indicate that WF has similar effects to those of proteolysis-inducing factor, but is less potent than the latter. Further studies are required to determine the precise role of WF in this experimental model. {\circledC} 2008 Yano et al; licensee BioMed Central Ltd.",
keywords = "advanced cancer, cachexia, weight loss, tumoral factors, humoral factors, fat stores, muscular tissue, cytotoxicity assays, enzymatic assays, morphological analysis, proteolysis-inducing factor (PIF)-like molecule, ascitic fluid of, Walker tumour-bearing rats, muscle atrophy, cultured C2C12 muscle cells, C2C12 myotubes, pro-oxidant malondialdehyde, chymotrypsin-like enzyme activity",
author = "Yano, {Claudia L.} and Gislaine Ventrucci and Field, {William N.} and Tisdale, {Michael J.} and Gomes-Marcondes, {Maria Cristina C.}",
note = "{\circledC} 2008 Yano et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",
year = "2008",
month = "1",
day = "28",
doi = "10.1186/1471-2407-8-24",
language = "English",
volume = "8",
pages = "24--",
journal = "BMC Cancer",
issn = "1471-2407",
publisher = "BioMed Central",
number = "24",

}

Metabolic and morphological alterations induced by proteolysis-inducing factor from Walker tumour-bearing rats in C2C12 myotubes. / Yano, Claudia L.; Ventrucci, Gislaine; Field, William N.; Tisdale, Michael J.; Gomes-Marcondes, Maria Cristina C.

In: BMC Cancer, Vol. 8, No. 24, 28.01.2008, p. 24-.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Metabolic and morphological alterations induced by proteolysis-inducing factor from Walker tumour-bearing rats in C2C12 myotubes

AU - Yano, Claudia L.

AU - Ventrucci, Gislaine

AU - Field, William N.

AU - Tisdale, Michael J.

AU - Gomes-Marcondes, Maria Cristina C.

N1 - © 2008 Yano et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PY - 2008/1/28

Y1 - 2008/1/28

N2 - BACKGROUND: Patients with advanced cancer suffer from cachexia, which is characterised by a marked weight loss, and is invariably associated with the presence of tumoral and humoral factors which are mainly responsible for the depletion of fat stores and muscular tissue. METHODS: In this work, we used cytotoxicity and enzymatic assays and morphological analysis to examine the effects of a proteolysis-inducing factor (PIF)-like molecule purified from ascitic fluid of Walker tumour-bearing rats (WF), which has been suggested to be responsible for muscle atrophy, on cultured C2C12 muscle cells. RESULTS: WF decreased the viability of C2C12 myotubes, especially at concentrations of 20-25 mug.mL-1. There was an increase in the content of the pro-oxidant malondialdehyde, and a decrease in antioxidant enzyme activity. Myotubes protein synthesis decreased and protein degradation increased together with an enhanced in the chymotrypsin-like enzyme activity, a measure of functional proteasome activity, after treatment with WF. Morphological alterations such as cell retraction and the presence of numerous cells in suspension were observed, particularly at high WF concentrations. CONCLUSION: These results indicate that WF has similar effects to those of proteolysis-inducing factor, but is less potent than the latter. Further studies are required to determine the precise role of WF in this experimental model. © 2008 Yano et al; licensee BioMed Central Ltd.

AB - BACKGROUND: Patients with advanced cancer suffer from cachexia, which is characterised by a marked weight loss, and is invariably associated with the presence of tumoral and humoral factors which are mainly responsible for the depletion of fat stores and muscular tissue. METHODS: In this work, we used cytotoxicity and enzymatic assays and morphological analysis to examine the effects of a proteolysis-inducing factor (PIF)-like molecule purified from ascitic fluid of Walker tumour-bearing rats (WF), which has been suggested to be responsible for muscle atrophy, on cultured C2C12 muscle cells. RESULTS: WF decreased the viability of C2C12 myotubes, especially at concentrations of 20-25 mug.mL-1. There was an increase in the content of the pro-oxidant malondialdehyde, and a decrease in antioxidant enzyme activity. Myotubes protein synthesis decreased and protein degradation increased together with an enhanced in the chymotrypsin-like enzyme activity, a measure of functional proteasome activity, after treatment with WF. Morphological alterations such as cell retraction and the presence of numerous cells in suspension were observed, particularly at high WF concentrations. CONCLUSION: These results indicate that WF has similar effects to those of proteolysis-inducing factor, but is less potent than the latter. Further studies are required to determine the precise role of WF in this experimental model. © 2008 Yano et al; licensee BioMed Central Ltd.

KW - advanced cancer

KW - cachexia

KW - weight loss

KW - tumoral factors

KW - humoral factors

KW - fat stores

KW - muscular tissue

KW - cytotoxicity assays

KW - enzymatic assays

KW - morphological analysis

KW - proteolysis-inducing factor (PIF)-like molecule

KW - ascitic fluid of

KW - Walker tumour-bearing rats

KW - muscle atrophy

KW - cultured C2C12 muscle cells

KW - C2C12 myotubes

KW - pro-oxidant malondialdehyde

KW - chymotrypsin-like enzyme activity

UR - http://www.scopus.com/inward/record.url?scp=41649102306&partnerID=8YFLogxK

U2 - 10.1186/1471-2407-8-24

DO - 10.1186/1471-2407-8-24

M3 - Article

VL - 8

SP - 24-

JO - BMC Cancer

T2 - BMC Cancer

JF - BMC Cancer

SN - 1471-2407

IS - 24

ER -